Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.
Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N.
Ishiyama K, et al. Among authors: oka s.
Leukemia. 2017 Jan;31(1):268. doi: 10.1038/leu.2016.188.
Leukemia. 2017.
PMID: 28050024
No abstract available.